Booth No.4W-47
CategoryIngredients
PavilionChina Pavilion
Wanbang Biopharmaceuticals
Booth No.:4W-47
Category:Ingredients
Pavilion:China Pavilion
zhouyan1@fosunpharma.com
+86-186-2600-8050
Address: 221004
South of Dongshan, Comprehensive Area,Jinshanqiao Economic Development Zone, Xuzhou,Jiangsu, 310003 CHINA http://chinawanbang.com
South of Dongshan, Comprehensive Area,Jinshanqiao Economic Development Zone, Xuzhou,Jiangsu, 310003 CHINA http://chinawanbang.com
NA
Founded in 1981, Wanbang Biopharmaceuticals (Wanbang Biopharma) is a global innovation-driven pharmaceutical company deep-rooted in China, and is a core member enterprise of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196-SH, 02196-HK).
Our business covers the whole healthcare industry chain including R&D, manufacturing, wholesale, distribution, chain stores, and internet sales. Currently Wanbang Biopharma holds and controls 20 subsidiaries and has established 7 manufacturing sites across China. In the past decade, Wanbang maintained a CAGR 22.85% in sales revenue, which exceeded 7.9 billion RMB (1.2 billion USD) in 2022.
Wanbang Biopharma actively improve the quality system to international level. At present, more than 10 production lines have passed site inspection by overseas health authority and obtained certification, among which, one sterile injectable production line has passed the EU and US FDA site inspection, and one oral solid preparation production line has passed the US FDA site inspection.
Our business covers the whole healthcare industry chain including R&D, manufacturing, wholesale, distribution, chain stores, and internet sales. Currently Wanbang Biopharma holds and controls 20 subsidiaries and has established 7 manufacturing sites across China. In the past decade, Wanbang maintained a CAGR 22.85% in sales revenue, which exceeded 7.9 billion RMB (1.2 billion USD) in 2022.
Wanbang Biopharma actively improve the quality system to international level. At present, more than 10 production lines have passed site inspection by overseas health authority and obtained certification, among which, one sterile injectable production line has passed the EU and US FDA site inspection, and one oral solid preparation production line has passed the US FDA site inspection.
Company information
Address | 221004 South of Dongshan, Comprehensive Area,Jinshanqiao Economic Development Zone, Xuzhou,Jiangsu, 310003 CHINA |
---|---|
TEL | +86-186-2600-8050 |
FAX | +86-186-2600-8050 |
URL | http://chinawanbang.com |
zhouyan1@fosunpharma.com |
Product Classification |
Carisoprodol Tablets Leflunomide Tablets Dapagliflozin Tablets Sitagliptin Tablets Guanfacine ER Tablets Apixaban Tablets Rivaroxaban Tablets Febuxostat Tablets Ticagrelor Tablets Empagliflozin Tablets |
---|
Contact in Japan
Japan Agent | NA |
---|